Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Alpha Cognition Inc (ACOG.VN)

Alpha Cognition Inc (ACOG.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 22,536
  • Shares Outstanding, K 93,901
  • Annual Sales, $ 0 K
  • Annual Income, $ -12,115 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade ACOG.VN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.18
  • Most Recent Earnings $-0.06 on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.210 +14.29%
on 03/30/23
0.280 -14.29%
on 03/29/23
-0.055 (-18.64%)
since 03/24/23
3-Month
0.210 +14.29%
on 03/30/23
0.490 -51.02%
on 03/06/23
-0.150 (-38.46%)
since 01/25/23
52-Week
0.210 +14.29%
on 03/30/23
1.030 -76.70%
on 04/29/22
-0.760 (-76.00%)
since 04/25/22

Most Recent Stories

More News
Alpha Cognition Announces Fourth Quarter and Full Year 2022 Results and Provides Corporate Update

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...

ACOG.VN : 0.240 (unch)
ACOGF : 0.5050 (-4.72%)
Alpha Cognition Provides Private Placement Update

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“ Alpha Cognition ”, or the “ Company ”), a biopharmaceutical company developing novel therapies for debilitating neurodegenerative disorders,...

ACOG.VN : 0.240 (unch)
ACOGF : 0.5050 (-4.72%)
Alpha Cognition Announces Third Quarter 2022 Results and Provides Corporate Update

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...

ACOG.VN : 0.240 (unch)
ACOGF : 0.5050 (-4.72%)
Alpha Cognition Announces Second Quarter 2022 Results and Provides Corporate Update

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...

ACOG.VN : 0.240 (unch)
ACOGF : 0.5050 (-4.72%)
Alpha Cognition Announces Positive Topline Results from Bioequivalence Study with ALPHA-1062 in Development for Alzheimer’s Disease

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition,” or the “Company”), a biopharmaceutical company committed to developing novel therapies for people with debilitating neurodegenerative...

ACOG.VN : 0.240 (unch)
ACOGF : 0.5050 (-4.72%)
Alpha Cognition Announces Positive Results from Pivotal Study with ALPHA-1062 in Development for Alzheimer’s Disease

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies for people with debilitating neurodegenerative...

ACOG.VN : 0.240 (unch)
ACOGF : 0.5050 (-4.72%)
Alpha Cognition Announces Successful Defense of European Patent Covering ALPHA-0602

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...

ACOG.VN : 0.240 (unch)
ACOGF : 0.5050 (-4.72%)
Alpha Cognition Announces Positive Data from Pre-Clinical Studies and Discovery of GEM Combinations with Potential for Neurodegenerative Disease Treatment

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition” (ACI), or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders,...

ACOG.VN : 0.240 (unch)
ACOGF : 0.5050 (-4.72%)
Alpha Cognition Announces Grant of Stock Options

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition,” or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...

ACOG.VN : 0.240 (unch)
ACOGF : 0.5050 (-4.72%)
Alpha Cognition Announces First Quarter 2022 Results and Company Update

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...

ACOG.VN : 0.240 (unch)
ACOGF : 0.5050 (-4.72%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Alpha Cognition Inc is in the business of researching and developing pharmaceutical treatments for neurological diseases. The Company operates from its three offices located in Charlottetown, Prince Edward Island; Vancouver, British Columbia; and Frisco, Texas.

See More

Key Turning Points

3rd Resistance Point 0.253
2nd Resistance Point 0.247
1st Resistance Point 0.243
Last Price 0.240
1st Support Level 0.233
2nd Support Level 0.227
3rd Support Level 0.223

See More

52-Week High 1.030
Fibonacci 61.8% 0.717
Fibonacci 50% 0.620
Fibonacci 38.2% 0.523
Last Price 0.240
52-Week Low 0.210

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar